SCHEMBL29453662

SCHEMBL29453662

N#CC1(Cc2ccc(Cl)cc2Br)CCN(C(=O)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 8/20 0.54
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ P2RX7 Q99572 2/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PROKR1 Q8TCW9 2/20 0.34
▸ FPR2 P25090 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ AVPR1A P37288 2/20 0.33
▸ MGLL Q99685 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719291 1.00 CYP46A1 (0.54) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453690 0.90 CYP46A1 (0.54) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719126 0.90 CYP46A1 (0.54) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719355 0.88 CYP46A1 (0.52) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453695 0.88 CYP46A1 (0.52) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719288 0.87 CYP46A1 (0.64) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453691 0.87 CYP46A1 (0.64) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453776 0.86 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719369 0.86 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719375 0.84 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback